Prevalence and risk factors for insomnia among breast cancer patients on aromatase inhibitors

摘要

PurposeInsomnia is increasingly recognized as a major symptom outcome in breast cancer; however, little is known about its prevalence and risk factors among women receiving aromatase inhibitors (AIs), a standard treatment to increase disease free survival among breast cancer patients.